Although clinical severity was not assessed in our study, it is possible that the determination of hepcidin may add valuable information to routinely used biomarkers for evaluating bacterial infections at baseline and during their course, after the administration of the appropriate antibiotic treatment. The gene discussed is HAMP; the disease is bacterial infectious disease.